endogenous glp-1 Drugs and the Physiology of Metabolic Health GLP-1 receptor agonists for individualized

Atherosclerosis 188, 455461 (2006)

Maintaining adequate hydration is critical to prevent acute kidney injury as well as heart palpitations

As of early 2026, GLP-1 receptor agonists have treated tens of millions worldwide ( [153] ), and that number is rapidly growing as new indications expand

August 2013 MDL created August 2013 MDL created for federal lawsuits alleging injuries from incretin mimetic diabetes drugs

Amyotrophic lateral sclerosis associated disturbance of iron metabolism is blunted by swim training-role of AKT signaling pathway

They argue that cities and states will then have to pay for more health problems related to obesity